STOCK TITAN

INTEGRATED BIOPHARMA INC (INBP) Net Income by Year

INBP

INTEGRATED BIOPHARMA INC reported $808K in net income in fiscal year 2025. This represents an increase of 621.4% from the prior fiscal year. Over the trailing 12 months, Q4 FY2025 through Q3 FY2026, the same line adds up to a $1.7M net loss. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters INTEGRATED BIOPHARMA INC has filed alongside them.

FY2025 annual
Net Income $808K
YoY +621.4%
5Y CAGR -27.8%
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Mar 31, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

INBP Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1710-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-K
Net Income-$1.7M$808K+621.4%$112K+429.4%-$34K-100.9%$3.8M-52.1%$8.0M+95.1%$4.1M+143.4%$1.7M+148.6%$679KN/A$810K$735K+461.1%$131K+40.9%$93K+103.4%-$2.7M-18.9%-$2.3M

TTM is the trailing twelve months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings.

INBP Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-KQ4'2310-K
Net Income-$837K-237.0%-$762K-756.9%$123K-52.5%-$178K-166.4%$611K+114.4%$116K+130.4%$259K+539.0%$268K+570.0%$285K+1681.3%-$382K-594.5%-$59K-68.6%$40K-97.3%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More INTEGRATED BIOPHARMA INC financials

Frequently Asked Questions

What was INTEGRATED BIOPHARMA INC's net income in fiscal year 2025?

INTEGRATED BIOPHARMA INC reported $808K in net income in fiscal year 2025.

How fast is INTEGRATED BIOPHARMA INC's net income growing?

INTEGRATED BIOPHARMA INC (INBP) net income rose by 621.4% year over year, from $112K to $808K in fiscal year 2025.

What is INTEGRATED BIOPHARMA INC's net income over the last twelve months?

INTEGRATED BIOPHARMA INC (INBP) reported a $1.7M net loss over the trailing 12 months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings.

Across the 15 fiscal years this page covers, INTEGRATED BIOPHARMA INC (INBP) net income went from -$2.3M in fiscal year 2011 to $808K in fiscal year 2025.

INTEGRATED BIOPHARMA INC (INBP) reported -$837K in net income in Q3 2026. This represents a decrease of 237.0% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what INTEGRATED BIOPHARMA INC (INBP) reported on that line in every period on record.